CN101246158B - 测定血细胞中白细胞的溶血剂 - Google Patents
测定血细胞中白细胞的溶血剂 Download PDFInfo
- Publication number
- CN101246158B CN101246158B CN2008100107183A CN200810010718A CN101246158B CN 101246158 B CN101246158 B CN 101246158B CN 2008100107183 A CN2008100107183 A CN 2008100107183A CN 200810010718 A CN200810010718 A CN 200810010718A CN 101246158 B CN101246158 B CN 101246158B
- Authority
- CN
- China
- Prior art keywords
- hemolytic agent
- blood cells
- white blood
- cosolvent
- buffer solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003219 hemolytic agent Substances 0.000 title claims abstract description 45
- 210000000265 leukocyte Anatomy 0.000 title claims abstract description 40
- 210000003677 hemocyte Anatomy 0.000 title description 3
- 229940000351 hemocyte Drugs 0.000 title description 3
- 210000000601 blood cell Anatomy 0.000 claims abstract description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000008367 deionised water Substances 0.000 claims abstract description 15
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 13
- 239000006184 cosolvent Substances 0.000 claims abstract description 12
- -1 polyoxyethylene Polymers 0.000 claims abstract description 10
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims abstract description 8
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical group O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 14
- 239000007853 buffer solution Substances 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 230000003204 osmotic effect Effects 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 5
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 claims description 4
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000003242 quaternary ammonium salts Chemical group 0.000 claims description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 claims description 4
- 235000011152 sodium sulphate Nutrition 0.000 claims description 4
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 2
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000000304 alkynyl group Chemical group 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000000872 buffer Substances 0.000 abstract description 14
- 238000012360 testing method Methods 0.000 abstract description 7
- 239000000834 fixative Substances 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 abstract 1
- 102000001554 Hemoglobins Human genes 0.000 description 14
- 108010054147 Hemoglobins Proteins 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000003743 erythrocyte Anatomy 0.000 description 11
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 239000003085 diluting agent Substances 0.000 description 9
- 238000001514 detection method Methods 0.000 description 8
- 238000007865 diluting Methods 0.000 description 6
- 210000000170 cell membrane Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000001616 monocyte Anatomy 0.000 description 4
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 3
- 238000004820 blood count Methods 0.000 description 3
- 210000003714 granulocyte Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 210000000440 neutrophil Anatomy 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- UQGFMSUEHSUPRD-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane Chemical compound [Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 UQGFMSUEHSUPRD-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 210000003651 basophil Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000003979 eosinophil Anatomy 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
Images
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
参数名称 | pH | 渗透压 | 电导率 | 比重 |
范围值 | 5.2~9.1 | 140~650mOsm/kg | 6.2~9.1mS/cm | 0.9~1.22 |
项目 | 正常健康人 | 生理性贫血者 | 细菌感染患者 |
白细胞 | 8.1 10E3/uL | 6.7 10E3/uL | 13.8 10E3/uL |
中性粒细胞 | 59% | 65% | 79% |
单核细胞 | 4% | 6% | 3% |
淋巴细胞 | 37% | 29% | 18% |
红细胞 | 4.30 10E3/uL | 3.80 10E3/uL | 4.10 10E3/uL |
血小板 | 310 10E3/uL | 263 10E3/uL | 281 10E3/uL |
血红蛋白 | 153g/L | 103g/L | 137g/L |
类别 | WBC×109/L | LY% | MO% | GRA% | RBC×1012/L | HGBg/L | PLT×109/L |
低值质控进口溶血剂实施例5溶血剂 | 2.22.332.30 | 62.059.860.9 | 6.06.16.0 | 32.030.123.1 | 2.362.402.40 | 616260 | 535252 |
中值质控进口溶血剂实施例5溶血剂 | 6.97.17.1 | 30.033.831.0 | 7.16.87.1 | 62.959.461.9 | 4.654.644.64 | 137137136 | 240242242 |
高值质控进口溶血剂实施例5溶血剂 | 17.917.817.9 | 16.016.416.6 | 4.64.94.4 | 79.478.779.0 | 5.655.665.67 | 186187185 | 510513513 |
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100107183A CN101246158B (zh) | 2008-03-21 | 2008-03-21 | 测定血细胞中白细胞的溶血剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100107183A CN101246158B (zh) | 2008-03-21 | 2008-03-21 | 测定血细胞中白细胞的溶血剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101246158A CN101246158A (zh) | 2008-08-20 |
CN101246158B true CN101246158B (zh) | 2012-04-18 |
Family
ID=39946733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100107183A Active CN101246158B (zh) | 2008-03-21 | 2008-03-21 | 测定血细胞中白细胞的溶血剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101246158B (zh) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102226804B (zh) * | 2011-03-28 | 2013-07-03 | 中国人民解放军总医院 | 一种用于血液白细胞五分类计数的溶血剂及其用途 |
WO2014069519A1 (ja) * | 2012-10-30 | 2014-05-08 | 学校法人金沢医科大学 | 透明化生物標本作製用キット及び透明化生物標本作製方法 |
CN108931461B (zh) * | 2013-03-12 | 2021-09-07 | 雅培实验室 | 用于分析白细胞的试剂、体系及方法 |
HUE041665T2 (hu) * | 2014-02-28 | 2019-05-28 | Sysmex Corp | Eljárás vizeletminta elemzésére, reagens alkalmazása vizeletminta elemzésére és reagenskészlet alkalmazása vizeletminta elemzésére |
CN107101933A (zh) * | 2017-07-10 | 2017-08-29 | 郑州金域临床检验中心(普通合伙) | 一种血液分析组合物及其应用 |
CN108226127B (zh) * | 2017-12-26 | 2021-04-06 | 深圳国际旅行卫生保健中心 | 测定疟原虫含量的方法和检测疟原虫含量的系统 |
CN111413176B (zh) * | 2020-05-09 | 2023-05-16 | 河北艾驰生物科技有限公司 | 一种尿液有形成分分析用红细胞和白细胞质控物质及其制备方法 |
-
2008
- 2008-03-21 CN CN2008100107183A patent/CN101246158B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101246158A (zh) | 2008-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101246158B (zh) | 测定血细胞中白细胞的溶血剂 | |
US4346018A (en) | Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes | |
US4521518A (en) | Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes | |
CA1117401A (en) | Multi-purpose blood diluent for use in electronic blood analysis instrumentation | |
JP4889730B2 (ja) | シアニドを含まない溶解試薬組成物;ならびにヘモグロビンおよび白血球の測定のための使用の方法 | |
CN102226804B (zh) | 一种用于血液白细胞五分类计数的溶血剂及其用途 | |
EP0627624B1 (en) | System for isolating and identifying leukocytes | |
EP0144339B1 (en) | Method and stromatolysing reagent for the volumetric determination of populations of leukocytes | |
JP2619900B2 (ja) | 血液中の白血球およびヘモグロビンの測定用試薬および方法 | |
US6632676B1 (en) | Multi-purpose reagent system and method for enumeration of red blood cells, white blood cells and thrombocytes and differential determination of white blood cells | |
US4962038A (en) | Multi-purpose blood diluent and lysing agent for differential determination of lymphoid-myeloid population of leukocytes | |
EP1810025B1 (en) | Lysing reagent for simultaneous enumeration of different types of blood cells in a blood sample | |
US20020098589A1 (en) | Multi-purpose reagent system and method for enumeration of red blood cells, white blood cells and thrombocytes and differential determination of white blood cells | |
EP1684075A2 (en) | Method and reagent for classifying leukocytes in animal blood | |
JP2008032750A (ja) | ヘモグロビン及び細胞分析のためのシアン化物不含溶解試薬組成物及び方法 | |
JPS6073356A (ja) | 血液分析用試薬 | |
WO2003012426A1 (en) | Lytic reagent composition for determination of nucleated red blood cells | |
CN107976397B (zh) | 一种溶血剂及其制备方法 | |
CN110470587B (zh) | 一种五分类血细胞分析仪用嗜碱性粒细胞计数套装 | |
CN108169468B (zh) | 一种适用于多种血液分析仪的稀释液及其配置方法 | |
CN114047107A (zh) | 一种血细胞分析用稀释液 | |
EP3794346A1 (en) | Green concentrated reagent for hematology systems | |
CN109142196A (zh) | 一种三分类血细胞分析仪用试剂 | |
JP4391489B2 (ja) | 血液中のヘモグロビン濃度測定方法 | |
Weiser et al. | Cytoplasmic fragmentation associated with lymphoid leukemia in ruminants: interference with electronic determination of platelet concentration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20080820 Assignee: LABNOVATION TECHNOLOGIES, INC. Assignor: Wang Yadong Contract record no.: 2013440020240 Denomination of invention: Hemolytic agent for measuring white blood cell in hemocyte Granted publication date: 20120418 License type: Exclusive License Record date: 20130805 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170512 Address after: 518000, Shenzhen, Guangdong province Nanshan District hi tech Industrial Park, two South Road, science and technology, W2-B, building on the first floor of the East Patentee after: LABNOVATION TECHNOLOGIES, INC. Address before: 116013, 3-1-1, building 52, highland street, Zhongshan District, Liaoning, Dalian Patentee before: Wang Yadong |
|
TR01 | Transfer of patent right | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: LABNOVATION TECHNOLOGIES, INC. Assignor: Wang Yadong Contract record no.: 2013440020240 Date of cancellation: 20170527 |
|
EC01 | Cancellation of recordation of patent licensing contract |